Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37359 | --- | --- | --- | |----------------------------------------------------------------------------------------- ...

Blueprint Medicines (NASDAQ:BPMC) Q4 2018 Earnings Conference Call February 26, 2019 8:30 AM ET Company Participants Jim Baker - Vice President, Corporate Affairs Jeff Albers - Chief Executive Officer Kate Haviland - Chief Operating Officer Andy Boral - Chief Medical Officer Mike Landsittel - Chief Finance Officer Conference Call Participants Jason Jakoby - Goldman Sachs Marc Frahm - Cowen and Company Arlinda Lee - Canaccord Charles Zhu - Guggenheim Partners Operator Good day, ladies and gentlemen, and welc ...